Duke Health

Skip to main content

COVID

Probiotics Reduce COVID Symptoms and Delay Disease Among Unvaccinated
Probiotics Reduce COVID Symptoms and Delay Disease Among Unvaccinated
|
  • Research
  • COVID
Single Vaccine Protects Against Three Deadly Strains of Coronavirus
Single Vaccine Protects Against Three Deadly Strains of Coronavirus
|
  • Research
  • COVID
  • Infectious Disease
Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
|
  • Research
  • COVID
A Reflection: The Official End of the COVID-19 Public Health Emergency
A Reflection: The Official End of the COVID-19 Public Health Emergency
|
  • Clinical Care
  • Education
  • Health System
  • Research
  • Infectious Disease
  • COVID
  • Organization News
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
|
  • Research
  • COVID
  • Infectious Disease
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
|
  • Research
  • COVID
  • Infectious Disease
DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative
DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative
|
  • Research
  • COVID
  • Infectious Disease
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
|
  • Research
  • COVID
  • Infectious Disease
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
|
  • Research
  • COVID
  • Infectious Disease
Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
|
  • Research
  • COVID
  • Infectious Disease
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
|
  • Research
  • COVID
Investigational Mucosal COVID Vaccine Protects Against Disease and Transmission
Investigational Mucosal COVID Vaccine Protects Against Disease and Transmission
|
  • Research
  • COVID
  • Infectious Disease
Indications of Moral Injury Similar between Combat Veterans and COVID-19 Health Care Workers
Indications of Moral Injury Similar between Combat Veterans and COVID-19 Health Care Workers
|
  • Research
  • Infectious Disease
  • Psychiatry
  • COVID
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
|
  • Research
  • Children's Health
  • Infectious Disease
  • COVID
Incidence of COVID-19 was 8 Times Higher in Unvaccinated vs. Vaccinated Students
Incidence of COVID-19 was 8 Times Higher in Unvaccinated vs. Vaccinated Students
|
  • Research
  • COVID
  • Children's Health
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
|
  • Research
  • Infectious Disease
  • COVID
Omicron Antibodies Persist 6 Months after Moderna Vaccine Boost But Are 6 Times Lower
Omicron Antibodies Persist 6 Months after Moderna Vaccine Boost But Are 6 Times Lower
|
  • Clinical Care
  • Health System
  • Research
  • COVID
  • Infectious Disease
Hospital Room Surfaces Pose Low Risk of Spreading SARS-CoV-2
Hospital Room Surfaces Pose Low Risk of Spreading SARS-CoV-2
|
  • Research
  • Infectious Disease
  • COVID
With ‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
With ‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
|
  • Research
  • Children's Health
  • Infectious Disease
  • COVID
Duke Physicians Discuss Details of Omicron Variant
Duke Physicians Discuss Details of Omicron Variant
|
  • Clinical Care
  • Health System
  • Research
  • Infectious Disease
  • COVID
Duke, UNC-Chapel Hill Scientists Identify New Antibody For COVID-19 and Variants
Duke, UNC-Chapel Hill Scientists Identify New Antibody For COVID-19 and Variants
|
  • Research
  • Infectious Disease
  • COVID
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
|
  • Grants/Awards
  • COVID
  • Infectious Disease
Pandemic Response Shows Path For Improved Health Care in the Future
Pandemic Response Shows Path For Improved Health Care in the Future
|
  • Clinical Care
  • COVID
  • Infectious Disease
  • Primary Care
Nationwide Clinical Study Expands Platform to Test Medications to Treat Mild-to-Moderate COVID-19
Nationwide Clinical Study Expands Platform to Test Medications to Treat Mild-to-Moderate COVID-19
|
  • Research
  • Infectious Disease
  • COVID
Study Will Determine Rate of COVID Heart Inflammation Among Elite Athletes
Study Will Determine Rate of COVID Heart Inflammation Among Elite Athletes
|
  • Research
  • Heart
  • COVID
Subscribe to COVID